Gastric Cancers
17
9
15
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (17)
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
Validation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy
Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer
Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
QL1706 Combined With SOX Used in Theperioperative Treatment
Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer
The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome
Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.
Predictive Value of Air Pollution and Metabolomics for Gastric Cancer.
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer Patients